sign in
sign in
register
Rules
Sign in with Facebook
Sign in with Linkedin
Remember me
INVESTORS
My Home
Small Cap Marketplace
Broadcast Center
Request New Hub
Quick Tips
Ratings & Ranks
PUBLIC COMPANIES
Investor Relations
Success Stories
Clients
Testimonials
Contact
Conferences
About us
...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Message: July 15, 2016
Reply
New Message
Back To Forum
List View
Stock2740
Rank:
Treasurer
[?]
Points:
330
[?]
Votes:
10
Score:
2.2
[?]
Your Vote:
Please Log In to Vote
Follow
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
July 15, 2016
posted on Jul 06, 2016 04:15PM
Log in to use the IP Check tool
[?]
So is this the the official reorganization date ? Stock ...
Re: July 15, 2016
4
BearDownAZ
Jul 06, 2016 08:58PM
Dosing schedule for ZEN-3694
6
BearDownAZ
Jul 13, 2016 05:10PM
Reply
New Message
Back To Forum
List View
Share
Share
Share
Share
New Message
Please
login
to post a reply
Log in to Agoracom
Sign in with Facebook
Sign in with Linkedin
Remember me